Patients with Chronic Lymphocytic Leukemia Have a Very High Risk of Ineffective Response to the BNT162b2 Vaccine
暂无分享,去创建一个
G. Angioni | G. Caocci | G. la Nasa | M. Greco | O. Mulas | S. Oppi | R. Murru | S. Massidda | A. Galitzia | L. Barabino | A. Costa | G. La Nasa